{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T19:43:00Z","timestamp":1790797380231,"version":"4.1.0"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,7,9]],"date-time":"2021-07-09T00:00:00Z","timestamp":1625788800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,7,9]],"date-time":"2021-07-09T00:00:00Z","timestamp":1625788800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Leukemia"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1038\/s41375-021-01311-4","type":"journal-article","created":{"date-parts":[[2021,7,9]],"date-time":"2021-07-09T16:03:36Z","timestamp":1625846616000},"page":"177-188","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Expression patterns and prognostic potential of circular RNAs in mantle cell lymphoma: a study of younger patients from the MCL2 and MCL3 clinical trials"],"prefix":"10.1038","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5322-0136","authenticated-orcid":false,"given":"Mette","family":"Dahl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Husby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian W.","family":"Eskelund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1455-1738","authenticated-orcid":false,"given":"S\u00f8ren","family":"Besenbacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00f8ren","family":"Fjelstrup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5229-4440","authenticated-orcid":false,"given":"Christophe","family":"C\u00f4me","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1388-4912","authenticated-orcid":false,"given":"Sara","family":"Ek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arne","family":"Kolstad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riikka","family":"R\u00e4ty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4509-6707","authenticated-orcid":false,"given":"Mats","family":"Jerkeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian H.","family":"Geisler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f8rgen","family":"Kjems","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5980-7939","authenticated-orcid":false,"given":"Lasse S.","family":"Kristensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1535-9601","authenticated-orcid":false,"given":"Kirsten","family":"Gr\u00f8nb\u00e6k","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,7,9]]},"reference":[{"key":"1311_CR1","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1111\/j.1365-2141.2012.09174.x","volume":"158","author":"CH Geisler","year":"2012","unstructured":"Geisler CH, Kolstad A, Laurell A, Jerkeman M, R\u00e4ty R, Andersen NS, et al. Nordic MCL2 trial update: six-year follow-up after intensive immunochemotherapy for untreated mantle cell lymphoma followed by BEAM or BEAC+ autologous stem-cell support: still very long survival but late relapses do occur. Br J Haematol. 2012;158:355\u201362.","journal-title":"Br J Haematol"},{"key":"1311_CR2","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/S0140-6736(16)00739-X","volume":"388","author":"O Hermine","year":"2016","unstructured":"Hermine O, Hoster E, Walewski J, Bosly A, Stilgenbauer S, Thieblemont C, et al. Addition of high-dose cytarabine to immunochemotherapy before autologous stem-cell transplantation in patients aged 65 years or younger with mantle cell lymphoma (MCL younger): a randomised, open-label, phase 3 trial of the European Mantle Cell Lymphoma Network. Lancet. 2016;388:565\u201375.","journal-title":"Lancet"},{"key":"1311_CR3","doi-asserted-by":"publisher","first-page":"80","DOI":"10.1111\/bjh.13796","volume":"172","author":"D Chihara","year":"2016","unstructured":"Chihara D, Cheah CY, Westin JR, Fayad LE, Rodriguez MA, Hagemeister FB, et al. Rituximab plus hyper-CVAD alternating with MTX\/Ara-C in patients with newly diagnosed mantle cell lymphoma: 15-year follow-up of a phase II study from the MD Anderson Cancer Center. Br J Haematol. 2016;172:80\u20138.","journal-title":"Br J Haematol"},{"key":"1311_CR4","doi-asserted-by":"publisher","first-page":"2687","DOI":"10.1182\/blood-2008-03-147025","volume":"112","author":"CH Geisler","year":"2008","unstructured":"Geisler CH, Kolstad A, Laurell A, Andersen NS, Pedersen LB, Jerkeman M, et al. Long-term progression-free survival of mantle cell lymphoma after intensive front-line immunochemotherapy with in vivo-purged stem cell rescue: a nonrandomized phase 2 multicenter study by the Nordic Lymphoma Group. Blood. 2008;112:2687\u201393.","journal-title":"Blood"},{"key":"1311_CR5","doi-asserted-by":"publisher","first-page":"iv62","DOI":"10.1093\/annonc\/mdx223","volume":"1","author":"M Dreyling","year":"2017","unstructured":"Dreyling M, Geisler C, Hermine O, Kluin-Nelemans HC, Le Gouill S, Rule S, et al. Newly diagnosed and relapsed mantle cell lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2017;1:iv62\u201371.","journal-title":"Ann Oncol"},{"key":"1311_CR6","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1111\/bjh.14241","volume":"175","author":"CW Eskelund","year":"2016","unstructured":"Eskelund CW, Kolstad A, Jerkeman M, R\u00e4ty R, Laurell A, Eloranta S, et al. 15-year follow-up of the Second Nordic Mantle Cell Lymphoma trial (MCL2): prolonged remissions without survival plateau. Br J Haematol. 2016;175:410\u20138.","journal-title":"Br J Haematol"},{"key":"1311_CR7","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1182\/blood-2007-06-095331","volume":"111","author":"E Hoster","year":"2008","unstructured":"Hoster E, Dreyling M, Klapper W, Gisselbrecht C, Van Hoof A, Kluin-Nelemans HC, et al. A new prognostic index (MIPI) for patients with advanced-stage mantle cell lymphoma. Blood. 2008;111:558\u201365.","journal-title":"Blood"},{"key":"1311_CR8","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1111\/j.1365-2141.2005.05716.x","volume":"131","author":"M Tiemann","year":"2005","unstructured":"Tiemann M, Schrader C, Klapper W, Dreyling MH, Campo E, Norton A, et al. Histopathology, cell proliferation indices and clinical outcome in 304 patients with mantle cell lymphoma (MCL): a clinicopathological study from the European MCL Network. Br J Haematol. 2005;131:29\u201338.","journal-title":"Br J Haematol"},{"issue":"Feb","key":"1311_CR9","doi-asserted-by":"publisher","first-page":"1386","DOI":"10.1200\/JCO.2015.63.8387","volume":"34","author":"E Hoster","year":"2016","unstructured":"Hoster E, Rosenwald A, Berger F, Bernd H-W, Hartmann S, Loddenkemper C, et al. Prognostic value of Ki-67 index, cytology, and growth pattern in mantle-cell lymphoma: results from randomized trials of the European Mantle Cell Lymphoma Network. J Clin Oncol. 2016;34:1386\u201394.","journal-title":"J Clin Oncol"},{"key":"1311_CR10","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/S1535-6108(03)00028-X","volume":"3","author":"A Rosenwald","year":"2003","unstructured":"Rosenwald A, Wright G, Wiestner A, Chan WC, Connors JM, Campo E, et al. The proliferation gene expression signature is a quantitative integrator of oncogenic events that predicts survival in mantle cell lymphoma. Cancer Cell. 2003;3:185\u201397.","journal-title":"Cancer Cell"},{"key":"1311_CR11","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1200\/JCO.2016.70.7901","volume":"35","author":"DW Scott","year":"2017","unstructured":"Scott DW, Abrisqueta P, Wright GW, Slack GW, Mottok A, Villa D, et al. New molecular assay for the proliferation signature in mantle cell lymphoma applicable to formalin-fixed paraffin-embedded biopsies. J Clin Oncol. 2017;35:1668\u201377.","journal-title":"J Clin Oncol"},{"key":"1311_CR12","doi-asserted-by":"publisher","first-page":"2669","DOI":"10.1182\/blood-2014-06-584193","volume":"125","author":"S Husby","year":"2015","unstructured":"Husby S, Ralfkiaer U, Garde C, Zandi R, Ek S, Kolstad A, et al. miR-18b overexpression identifies mantle cell lymphoma patients with poor outcome and improves the MIPI-B prognosticator. Blood. 2015;125:2669\u201377.","journal-title":"Blood"},{"key":"1311_CR13","doi-asserted-by":"publisher","DOI":"10.1007\/s11912-017-0598-1","volume":"19","author":"S Be\u00e0","year":"2017","unstructured":"Be\u00e0 S, Amador V. Role of SOX11 and genetic events cooperating with cyclin D1 in mantle cell lymphoma. Curr Oncol Rep. 2017;19:43.","journal-title":"Curr Oncol Rep"},{"key":"1311_CR14","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1182\/blood.2019002385","volume":"136","author":"P Pararajalingam","year":"2020","unstructured":"Pararajalingam P, Coyle KM, Arthur SE, Thomas N, Alcaide M, Meissner B, et al. Coding and noncoding drivers of mantle cell lymphoma identified through exome and genome sequencing. Blood. 2020;136:572\u201384.","journal-title":"Blood"},{"key":"1311_CR15","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1182\/blood.2020005289","volume":"136","author":"F Nadeu","year":"2020","unstructured":"Nadeu F, Martin-Garcia D, Clot G, D\u00edaz-Navarro A, Duran-Ferrer M, Navarro A, et al. Genomic and epigenomic insights into the origin, pathogenesis, and clinical behavior of mantle cell lymphoma subtypes. Blood. 2020;136:1419\u201332.","journal-title":"Blood"},{"key":"1311_CR16","doi-asserted-by":"publisher","first-page":"1903","DOI":"10.1182\/blood-2017-04-779736","volume":"130","author":"CW Eskelund","year":"2017","unstructured":"Eskelund CW, Dahl C, Hansen JW, Westman M, Kolstad A, Pedersen LB, et al. TP53 mutations identify younger mantle cell lymphoma patients who do not benefit from intensive chemoimmunotherapy. Blood. 2017;130:1903\u201310.","journal-title":"Blood"},{"key":"1311_CR17","doi-asserted-by":"publisher","first-page":"1604","DOI":"10.3324\/haematol.2018.214056","volume":"105","author":"S Ferrero","year":"2020","unstructured":"Ferrero S, Rossi D, Rinaldi A, Bruscaggin A, Spina V, Eskelund CW, et al. KMT2D mutations and TP53 disruptions are poor prognostic biomarkers in mantle cell lymphoma receiving high-dose therapy: a FIL study. Haematologica. 2020;105:1604\u201312.","journal-title":"Haematologica"},{"key":"1311_CR18","doi-asserted-by":"publisher","first-page":"e30733","DOI":"10.1371\/journal.pone.0030733","volume":"7","author":"J Salzman","year":"2012","unstructured":"Salzman J, Gawad C, Wang PL, Lacayo N, Brown PO. Circular RNAs are the predominant transcript isoform from hundreds of human genes in diverse cell types. PLoS ONE. 2012;7:e30733.","journal-title":"PLoS ONE"},{"key":"1311_CR19","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1007\/s00109-017-1582-9","volume":"95","author":"PG Maass","year":"2017","unstructured":"Maass PG, Gla\u017ear P, Memczak S, Dittmar G, Hollfinger I, Schreyer L, et al. A map of human circular RNAs in clinically relevant tissues. J Mol Med (Berl). 2017;95:1179\u201389.","journal-title":"J Mol Med (Berl)"},{"key":"1311_CR20","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.celrep.2016.03.058","volume":"15","author":"Y Zhang","year":"2016","unstructured":"Zhang Y, Xue W, Li X, Zhang J, Chen S, Zhang J-L, et al. The biogenesis of nascent circular RNAs. Cell Rep. 2016;15:611\u201324.","journal-title":"Cell Rep"},{"key":"1311_CR21","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1261\/rna.035667.112","volume":"19","author":"WR Jeck","year":"2013","unstructured":"Jeck WR, Sorrentino JA, Wang K, Slevin MK, Burd CE, Liu J, et al. Circular RNAs are abundant, conserved, and associated with ALU repeats. RNA. 2013;19:141\u201357.","journal-title":"RNA"},{"key":"1311_CR22","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1038\/nature11928","volume":"495","author":"S Memczak","year":"2013","unstructured":"Memczak S, Jens M, Elefsinioti A, Torti F, Krueger J, Rybak A, et al. Circular RNAs are a large class of animal RNAs with regulatory potency. Nature. 2013;495:333\u20138.","journal-title":"Nature"},{"key":"1311_CR23","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1038\/onc.2017.361","volume":"37","author":"LS Kristensen","year":"2017","unstructured":"Kristensen LS, Hansen TB, Ven\u00f8 MT, Kjems J. Circular RNAs in cancer: opportunities and challenges in the field. Oncogene. 2017;37:555\u201365.","journal-title":"Oncogene"},{"key":"1311_CR24","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1038\/nrg.2016.114","volume":"17","author":"L Szabo","year":"2016","unstructured":"Szabo L, Salzman J. Detecting circular RNAs: bioinformatic and experimental challenges. Nat Rev Genet. 2016;17:679\u201392.","journal-title":"Nat Rev Genet"},{"key":"1311_CR25","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1080\/13102818.2017.1398596","volume":"32","author":"DF Chen","year":"2018","unstructured":"Chen DF, Zhang LJ, Tan K, Jing Q. Application of droplet digital PCR in quantitative detection of the cell-free circulating circRNAs. Biotechnol Biotechnol Equip. 2018;32:116\u201323.","journal-title":"Biotechnol Biotechnol Equip"},{"key":"1311_CR26","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/nbt1385","volume":"26","author":"GK Geiss","year":"2008","unstructured":"Geiss GK, Bumgarner RE, Birditt B, Dahl T, Dowidar N, Dunaway DL, et al. Direct multiplexed measurement of gene expression with color-coded probe pairs. Nat Biotechnol. 2008;26:317\u201325.","journal-title":"Nat Biotechnol"},{"key":"1311_CR27","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1038\/s41374-018-0108-6","volume":"98","author":"M Dahl","year":"2018","unstructured":"Dahl M, Daugaard I, Andersen M, Hansen TB, Gr\u00f8nb\u00e6k K, Kjems J, et al. Enzyme-free digital counting of endogenous circular RNA molecules in B-cell malignancies. Lab Invest. 2018;98:1657\u201369.","journal-title":"Lab Invest"},{"key":"1311_CR28","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.molcel.2014.08.019","volume":"56","author":"R Ashwal-Fluss","year":"2014","unstructured":"Ashwal-Fluss R, Meyer M, Pamudurti NR, Ivanov A, Bartok O, Hanan M, et al. CircRNA biogenesis competes with Pre-mRNA splicing. Mol Cell. 2014;56:55\u201366.","journal-title":"Mol Cell"},{"key":"1311_CR29","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1038\/nsmb.2959","volume":"22","author":"Z Li","year":"2015","unstructured":"Li Z, Huang C, Bao C, Chen L, Lin M, Wang X, et al. Exon-intron circular RNAs regulate transcription in the nucleus. Nat Struct Mol Biol. 2015;22:256\u201364.","journal-title":"Nat Struct Mol Biol"},{"key":"1311_CR30","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1038\/nature11993","volume":"495","author":"TB Hansen","year":"2013","unstructured":"Hansen TB, Jensen TI, Clausen BH, Bramsen JB, Finsen B, Damgaard CK, et al. Natural RNA circles function as efficient microRNA sponges. Nature. 2013;495:384\u20138.","journal-title":"Nature"},{"key":"1311_CR31","doi-asserted-by":"publisher","first-page":"2846","DOI":"10.1093\/nar\/gkw027","volume":"44","author":"WW Du","year":"2016","unstructured":"Du WW, Yang W, Liu E, Yang Z, Dhaliwal P, Yang BB. Foxo3 circular RNA retards cell cycle progression via forming ternary complexes with p21 and CDK2. Nucleic Acids Res. 2016;44:2846\u201358.","journal-title":"Nucleic Acids Res"},{"key":"1311_CR32","doi-asserted-by":"publisher","first-page":"12429","DOI":"10.1038\/ncomms12429","volume":"7","author":"LM Holdt","year":"2016","unstructured":"Holdt LM, Stahringer A, Sass K, Pichler G, Kulak NA, Wilfert W, et al. Circular non-coding RNA ANRIL modulates ribosomal RNA maturation and atherosclerosis in humans. Nat Commun. 2016;7:12429.","journal-title":"Nat Commun"},{"key":"1311_CR33","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1080\/15476286.2017.1279788","volume":"14","author":"K Abdelmohsen","year":"2017","unstructured":"Abdelmohsen K, Panda AC, Munk R, Grammatikakis I, Dudekula DB, De S, et al. Identification of HuR target circular RNAs uncovers suppression of PABPN1 translation by CircPABPN1. RNA Biol. 2017;14:361\u20139.","journal-title":"RNA Biol"},{"key":"1311_CR34","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/s41576-019-0158-7","volume":"20","author":"LS Kristensen","year":"2019","unstructured":"Kristensen LS, Andersen MS, Stagsted LVW, Ebbesen KK, Hansen TB, Kjems J. The biogenesis, biology and characterization of circular RNAs. Nat Rev Genet. 2019;20:675\u201391.","journal-title":"Nat Rev Genet"},{"key":"1311_CR35","doi-asserted-by":"publisher","first-page":"2953","DOI":"10.1182\/blood-2013-12-541953","volume":"123","author":"A Kolstad","year":"2014","unstructured":"Kolstad A, Laurell A, Jerkeman M, Gr\u00f8nb\u00e6k K, Elonen E, R\u00e4ty R, et al. Nordic MCL-3 study: BEAM\/C conditioning intensified with 90Y-ibritumomab-tiuxetan in responding non-CR patients followed by autologous transplant in mantle cell lymphoma. Blood. 2014;123:2953\u20139.","journal-title":"Blood"},{"key":"1311_CR36","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-015-0801-3","volume":"16","author":"MT Ven\u00f8","year":"2015","unstructured":"Ven\u00f8 MT, Hansen TB, Ven\u00f8 ST, Clausen BH, Grebing M, Finsen B, et al. Spatio-temporal regulation of circular RNA expression during porcine embryonic brain development. Genome Biol. 2015;16:245.","journal-title":"Genome Biol"},{"key":"1311_CR37","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1016\/j.cmpb.2019.05.023","volume":"177","author":"M Og\u0142uszka","year":"2019","unstructured":"Og\u0142uszka M, Orzechowska M, J\u0119droszka D, Witas P, Bednarek AK. Evaluate cutpoints: adaptable continuous data distribution system for determining survival in Kaplan-Meier estimator. Comput Methods Programs Biomed. 2019;177:133\u20139.","journal-title":"Comput Methods Programs Biomed"},{"key":"1311_CR38","doi-asserted-by":"publisher","first-page":"1666","DOI":"10.1261\/rna.043687.113","volume":"20","author":"P Glazar","year":"2014","unstructured":"Glazar P, Papavasileiou P, Rajewsky N, Gla\u017ear P, Papavasileiou P, Rajewsky N. circBase: a database for circular RNAs. RNA. 2014;20:1666\u201370.","journal-title":"RNA"},{"key":"1311_CR39","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1016\/j.cell.2014.09.001","volume":"159","author":"XO Zhang","year":"2014","unstructured":"Zhang XO, Wang HB, Zhang Y, Lu X, Chen LL, Yang L. Complementary sequence-mediated exon circularization. Cell. 2014;159:134\u201347.","journal-title":"Cell"},{"key":"1311_CR40","doi-asserted-by":"publisher","first-page":"e58","DOI":"10.1093\/nar\/gkv1458","volume":"44","author":"TB Hansen","year":"2015","unstructured":"Hansen TB, Ven\u00f8 MT, Damgaard CK, Kjems J. Comparison of circular RNA prediction tools. Nucleic Acids Res. 2015;44:e58.","journal-title":"Nucleic Acids Res"},{"key":"1311_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-18355-2","volume":"11","author":"LS Kristensen","year":"2020","unstructured":"Kristensen LS, Ebbesen KK, Sokol M, Jakobsen T, Korsgaard U, Eriksen AC, et al. Spatial expression analyses of the putative oncogene ciRS-7 in cancer reshape the microRNA sponge theory. Nat Commun. 2020;11:4551.","journal-title":"Nat Commun"},{"key":"1311_CR42","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1016\/j.molcel.2017.02.017","volume":"66","author":"I Legnini","year":"2017","unstructured":"Legnini I, Di Timoteo G, Rossi F, Morlando M, Briganti F, Sthandier O, et al. Circ-ZNF609 is a circular RNA that can be translated and functions in myogenesis. Mol Cell. 2017;66:22\u201337.","journal-title":"Mol Cell"},{"key":"1311_CR43","doi-asserted-by":"publisher","first-page":"1299","DOI":"10.1038\/sj.leu.2403813","volume":"19","author":"I Wlodarska","year":"2005","unstructured":"Wlodarska I, Veyt E, De Paepe P, Vandenberghe P, Nooijen P, Theate I, et al. FOXP1, a gene highly expressed in a subset of diffuse large B-cell lymphoma, is recurrently targeted by genomic aberrations. Leukemia. 2005;19:1299\u2013305.","journal-title":"Leukemia"},{"key":"1311_CR44","doi-asserted-by":"publisher","first-page":"2576","DOI":"10.1182\/blood-2017-10-811927","volume":"130","author":"JD Licht","year":"2017","unstructured":"Licht JD. SETD2: a complex role in blood malignancy. Blood. 2017;130:2576\u20138.","journal-title":"Blood"},{"key":"1311_CR45","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1038\/s41591-018-0243-z","volume":"25","author":"R Agarwal","year":"2019","unstructured":"Agarwal R, Chan Y-C, Tam CS, Hunter T, Vassiliadis D, Teh CE, et al. Dynamic molecular monitoring reveals that SWI\u2013SNF mutations mediate resistance to ibrutinib plus venetoclax in mantle cell lymphoma. Nat Med. 2019;25:119\u201329.","journal-title":"Nat Med"},{"key":"1311_CR46","doi-asserted-by":"publisher","DOI":"10.1186\/s12920-019-0616-2","volume":"12","author":"L-I Moldovan","year":"2019","unstructured":"Moldovan L-I, Hansen TB, Ven\u00f8 MT, Okholm TLH, Andersen TL, Hager H, et al. High-throughput RNA sequencing from paired lesional- and non-lesional skin reveals major alterations in the psoriasis circRNAome. BMC Med Genomics. 2019;12:174.","journal-title":"BMC Med Genomics"},{"key":"1311_CR47","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-59660-6","volume":"10","author":"K Das Mahapatra","year":"2020","unstructured":"Das Mahapatra K, Pasquali L, S\u00f8ndergaard JN, Lapins J, Nemeth IB, Balt\u00e1s E, et al. A comprehensive analysis of coding and non-coding transcriptomic changes in cutaneous squamous cell carcinoma. Sci Rep. 2020;10:3637.","journal-title":"Sci Rep"},{"key":"1311_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/srep08057","volume":"5","author":"A Bachmayr-Heyda","year":"2015","unstructured":"Bachmayr-Heyda A, Reiner AT, Auer K, Sukhbaatar N, Aust S, Bachleitner-Hofmann T, et al. Correlation of circular RNA abundance with proliferation\u2013exemplified with colorectal and ovarian cancer, idiopathic lung fibrosis, and normal human tissues. Sci Rep. 2015;5:8057.","journal-title":"Sci Rep"},{"key":"1311_CR49","doi-asserted-by":"publisher","first-page":"10646","DOI":"10.1002\/jcp.27744","volume":"234","author":"Y Xiong","year":"2019","unstructured":"Xiong Y, Zhang J, Song C. CircRNA ZNF609 functions as a competitive endogenous RNA to regulate FOXP4 expression by sponging miR-138-5p in renal carcinoma. J Cell Physiol. 2019;234:10646\u201354.","journal-title":"J Cell Physiol"},{"key":"1311_CR50","first-page":"2817","volume":"23","author":"L Zhu","year":"2019","unstructured":"Zhu L, Liu Y, Yang Y, Mao X-M, Yin Z-D. CircRNA ZNF609 promotes growth and metastasis of nasopharyngeal carcinoma by competing with microRNA-150-5p. Eur Rev Med Pharmacol Sci. 2019;23:2817\u201326.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"1311_CR51","first-page":"9411","volume":"23","author":"Z Liu","year":"2019","unstructured":"Liu Z, Pan H-M, Xin L, Zhang Y, Zhang W-M, Cao P, et al. Circ-ZNF609 promotes carcinogenesis of gastric cancer cells by inhibiting miRNA-145-5p expression. Eur Rev Med Pharmacol Sci. 2019;23:9411\u20137.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"1311_CR52","doi-asserted-by":"publisher","first-page":"7773","DOI":"10.2147\/OTT.S253936","volume":"13","author":"X Liao","year":"2020","unstructured":"Liao X, Zhan W, Tian B, Luo Y, Gu F, Li R. Circular RNA ZNF609 promoted hepatocellular carcinoma progression by upregulating PAP2C expression via sponging miR-342-3p. OncoTargets Ther. 2020;13:7773\u201383.","journal-title":"OncoTargets Ther"},{"key":"1311_CR53","doi-asserted-by":"publisher","first-page":"3843","DOI":"10.1038\/s41388-019-0699-4","volume":"38","author":"F Rossi","year":"2019","unstructured":"Rossi F, Legnini I, Megiorni F, Colantoni A, Santini T, Morlando M, et al. Circ-ZNF609 regulates G1-S progression in rhabdomyosarcoma. Oncogene. 2019;38:3843\u201354.","journal-title":"Oncogene"},{"key":"1311_CR54","doi-asserted-by":"publisher","first-page":"982","DOI":"10.3389\/fonc.2020.00982","volume":"10","author":"Y Xie","year":"2020","unstructured":"Xie Y, Li J, Li P, Li N, Zhang Y, Binang H, et al. RNA-Seq profiling of serum exosomal circular RNAs reveals circ-PNN as a potential biomarker for human colorectal cancer. Front Oncol. 2020;10:982.","journal-title":"Front Oncol"},{"key":"1311_CR55","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1080\/15476286.2015.1128065","volume":"13","author":"DB Dudekula","year":"2016","unstructured":"Dudekula DB, Panda AC, Grammatikakis I, De S, Abdelmohsen K, Gorospe M. CircInteractome: a web tool for exploring circular RNAs and their interacting proteins and microRNAs. RNA Biol. 2016;13:34\u201342.","journal-title":"RNA Biol"},{"key":"1311_CR56","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1007\/s12308-009-0036-x","volume":"2","author":"W Klapper","year":"2009","unstructured":"Klapper W, Hoster E, Determann O, Oschlies I, van der Laak J, Berger F, et al. Ki-67 as a prognostic marker in mantle cell lymphoma\u2014consensus guidelines of the pathology panel of the European MCL Network. J Hematop. 2009;2:103\u201311.","journal-title":"J Hematop"},{"key":"1311_CR57","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1007\/s00428-020-02750-7","volume":"477","author":"GA Croci","year":"2020","unstructured":"Croci GA, Hoster E, Be\u00e0 S, Clot G, Enjuanes A, Scott DW, et al. Reproducibility of histologic prognostic parameters for mantle cell lymphoma: cytology, Ki67, p53 and SOX11. Virchows Arch. 2020;477:259\u201367.","journal-title":"Virchows Arch"},{"issue":"Oct","key":"1311_CR58","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s12308-020-00418-4","volume":"13","author":"CA Ramsower","year":"2020","unstructured":"Ramsower CA, Maguire A, Robetorye RS, Feldman AL, Syrbu SI, Rosenthal AC, et al. Clinical laboratory validation of the MCL35 assay for molecular risk stratification of mantle cell lymphoma. J Hematop. 2020;13:231\u20138.","journal-title":"J Hematop"},{"key":"1311_CR59","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1111\/bjh.15518","volume":"183","author":"H Holte","year":"2018","unstructured":"Holte H, Beiske K, Boyle M, Tr\u00f8en G, Blaker YN, Myklebust J, et al. The MCL35 gene expression proliferation assay predicts high-risk MCL patients in a Norwegian cohort of younger patients given intensive first line therapy. Br J Haematol. 2018;183:225\u201334.","journal-title":"Br J Haematol"},{"key":"1311_CR60","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1111\/bjh.15519","volume":"184","author":"H Rauert-Wunderlich","year":"2019","unstructured":"Rauert-Wunderlich H, Mottok A, Scott DW, Rimsza LM, Ott G, Klapper W, et al. Validation of the MCL35 gene expression proliferation assay in randomized trials of the European Mantle Cell Lymphoma Network. Br J Haematol. 2019;184:616\u201324.","journal-title":"Br J Haematol"}],"updated-by":[{"DOI":"10.1038\/s41375-022-01526-z","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2022,2,18]],"date-time":"2022-02-18T00:00:00Z","timestamp":1645142400000}}],"container-title":["Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41375-021-01311-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41375-021-01311-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41375-021-01311-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,29]],"date-time":"2022-10-29T00:03:10Z","timestamp":1667001790000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41375-021-01311-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,9]]},"references-count":60,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["1311"],"URL":"https:\/\/doi.org\/10.1038\/s41375-021-01311-4","relation":{"correction":[{"id-type":"doi","id":"10.1038\/s41375-022-01526-z","asserted-by":"object"}]},"ISSN":["0887-6924","1476-5551"],"issn-type":[{"value":"0887-6924","type":"print"},{"value":"1476-5551","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,9]]},"assertion":[{"value":"29 December 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 May 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 July 2021","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2022","order":5,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":6,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s41375-022-01526-z","URL":"https:\/\/doi.org\/10.1038\/s41375-022-01526-z","order":8,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}